title: Altered ADAR 2 equilibrium and 5HT(2C) R editing in the prefrontal cortex of ADAR 2 transgenic mice.
abstract: Modulation of serotonin signaling by RNA editing of the serotonin 2C receptor (5HT(2C) R) may be relevant to affective disorder as serotonin functions regulate mood and behavior. Previously, we observed enhanced endogenous behavioral despair in ADAR2 transgenic mice. As the transcript of the 5HT(2C) R is a substrate of ADAR2, we hypothesized that perturbed ADAR2 equilibrium in the prefrontal cortex of ADAR2 transgenic mice alters the normal distribution of edited amino acid isoforms of the 5HT(2C) R and modifies the receptor function in downstream basal extracellular signal-regulated kinase (ERK) signaling. We examined groups of naive control and ADAR2 transgenic mice and found significantly increased ADAR2 expression, increased RNA editing at A, C, D and E sites and significantly altered normal distribution of edited amino acid isoforms of the 5HT(2C) R with increased proportions of valine asparagine valine, valine serine valine, valine asparagine isoleucine, isoleucine asparagine valine and decreased isoleucine asparagine isoleucine amino acid isoforms of the 5HT(2C) R in ADAR2 transgenic mice. Localized serotonin levels (5-HT) were unchanged and perturbed ADAR2 equilibrium coincides with dysregulated edited amino acid isoforms of the 5HT(2C) R and reduced basal ERK signaling. These results altogether suggest that altered 5HT(2C) R function could be contributing to enhanced depression-like behavior of ADAR2 transgenic mice and further implicate ADAR2 as a contributing factor in cases of affective disorder.
authors: Department of Internal Medicine, University of Iowa, Iowa City, USA. minati-singh@uiowa.edu
authors: M
authors: M
authors: Singh
authors: M M
authors: MM
authors: Singh
authors: E
authors: E
authors: Na
authors: K
authors: K
authors: Agassandian
authors: M B
authors: MB
authors: Zimmerman
authors: A K
authors: AK
authors: Johnson
references: J Biol Chem. 2004 Feb 6;279(6):4952-61
references: 14613934
references: J Biol Chem. 2004 Jan 23;279(4):2945-54
references: 14602721
references: Mol Psychiatry. 2001 Jul;6(4):373-9
references: 11443520
references: RNA. 2005 Oct;11(10):1596-603
references: 16199765
references: Mol Pharmacol. 2004 Jan;65(1):252-6
references: 14722258
references: J Neurochem. 2003 Dec;87(6):1402-12
references: 14713296
references: Biochem Pharmacol. 2008 Nov 15;76(10):1276-87
references: 18812172
references: Br J Psychiatry Suppl. 1989 Dec;(8):25-31
references: 2692637
references: Biochem Pharmacol. 2008 Mar 1;75(5):997-1006
references: 18164691
references: Biochemistry. 2000 Oct 24;39(42):12875-84
references: 11041852
references: Brain Res. 2004 Sep 3;1019(1-2):259-64
references: 15306261
references: Cell. 1991 Oct 4;67(1):11-9
references: 1717158
references: J Biol Chem. 2007 Aug 3;282(31):22448-59
references: 17567573
references: Neurobiol Dis. 2008 Aug;31(2):278-85
references: 18586506
references: Neurosci Res. 2005 Sep;53(1):69-76
references: 16005997
references: J Biol Chem. 2004 Feb 6;279(6):4894-902
references: 14615479
references: Pharmacol Ther. 2008 Jul;119(1):7-23
references: 18554725
references: Sci STKE. 2002 May 21;2002(133):pe26
references: 12023441
references: Mol Cell. 2007 Nov 9;28(3):491-500
references: 17996712
references: Neurosci Res. 2006 May;55(1):96-104
references: 16580757
references: J Mol Biol. 1995 Sep 22;252(3):277-82
references: 7563048
references: Neurobiol Dis. 2010 Aug;39(2):169-80
references: 20394819
references: RNA. 2001 Jun;7(6):846-58
references: 11421361
references: J Neurosci. 2002 Apr 15;22(8):3251-61
references: 11943826
references: J Neurosci. 2002 Mar 1;22(5):1532-40
references: 11880483
references: Neuron. 1992 Jan;8(1):189-98
references: 1370372
references: J Neurochem. 2001 May;77(3):916-28
references: 11331420
references: Biochem Soc Trans. 2008 Jun;36(Pt 3):534-6
references: 18482000
references: J Pharmacol Sci. 2006;100(5):427-32
references: 16799258
references: RNA. 2007 May;13(5):698-703
references: 17369310
references: Gene. 2006 Nov 1;382:39-46
references: 16904273
references: Mol Cell Biol. 2006 Jan;26(2):480-8
references: 16382140
references: Nature. 2000 Jul 6;406(6791):78-81
references: 10894545
references: Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8895-900
references: 10430867
references: Physiol Behav. 2009 Jun 22;97(3-4):446-54
references: 19361536
references: J Neurosci. 2002 Dec 15;22(24):10529-32
references: 12486144
references: Neuroreport. 2010 Oct 27;21(15):993-7
references: 20802353
references: Mol Psychiatry. 2009 Mar;14(3):269-79
references: 18256615
references: Cell. 1980 Nov;22(1 Pt 1):7-8
references: 7000367
references: Br J Pharmacol. 2001 Sep;134(2):386-92
references: 11564657
references: Mol Psychiatry. 2001 Nov;6(6):610, 725-8
references: 11673802
references: Neurosci Lett. 2003 Aug 7;346(3):169-72
references: 12853111
references: J Biol Chem. 1989 May 5;264(13):7363-8
references: 2708369
references: Brain Res Mol Brain Res. 2004 Apr 29;124(1):70-8
references: 15093687
references: Neuropsychopharmacology. 1999 Aug;21(2 Suppl):82S-90S
references: 10432493
references: Brief Funct Genomic Proteomic. 2006 Mar;5(1):37-42
references: 16769676
references: Mol Pharmacol. 2010 Nov;78(5):818-26
references: 20699324
references: Nat Neurosci. 2001 Jun;4(6):565-6
references: 11369935
references: Mol Pharmacol. 2005 Sep;68(3):711-9
references: 15917433
references: Nature. 1997 May 15;387(6630):303-8
references: 9153397
references: J Neurochem. 2005 Jun;93(6):1603-15
references: 15935077
references: Neurochem Res. 2006 Feb;31(2):167-76
references: 16673176
references: Mol Psychiatry. 2008 Nov;13(11):1001-10
references: 17848916
references: Nucleic Acids Symp Ser (Oxf). 2007;(51):83-4
references: 18029597
references: Nature. 1999 May 6;399(6731):75-80
references: 10331393
references: Neuroreport. 2008 Feb 12;19(3):379-82
references: 18303585
references: Neuron. 2002 Apr 25;34(3):349-56
references: 11988167
references: Neuropsychopharmacology. 2008 Jan;33(1):73-83
references: 17882234
references: J Mol Biol. 1999 Aug 6;291(1):1-13
references: 10438602
references: Nucleic Acids Res. 2010 Jun;38(10):e118
references: 20185571
references: Behav Pharmacol. 2007 Sep;18(5-6):419-30
references: 17762510
references: RNA. 2000 May;6(5):755-67
references: 10836796
references: Mol Pharmacol. 2000 Oct;58(4):859-62
references: 10999958
references: Neuroscientist. 2003 Aug;9(4):237-42
references: 12934707
references: J Neurochem. 2000 Mar;74(3):1290-300
references: 10693963
references: Mol Pharmacol. 2010 Jun;77(6):895-902
references: 20181818
references: J Neurosci. 2005 Jan 19;25(3):648-51
references: 15659601
references: J Biol Chem. 2001 Nov 30;276(48):44663-8
references: 11572865
references: Neuropsychopharmacology. 2001 May;24(5):478-91
references: 11282248
references: Neuropharmacology. 2008 Nov;55(6):969-76
references: 18602407